Gemcitabine plus cisplain vs. gecitabine plus carboplatin in stage IIIb and IV non small cell lung cancer: A phase III randomized trial

Warning

This publication doesn't include Faculty of Economics and Administration. It includes Faculty of Medicine. Official publication website can be found on muni.cz.
Authors

ZATLOUKAL Petr PETRUŽELKA Luboš ZEMANOVÁ Milada KOLEK Vítězslav SKŘIČKOVÁ Jana PEŠEK Miloš FOITŮ Hana GRYGÁRKOVÁ Ivona SIXTOVÁ Dimka ROUBEC Jaromír

Year of publication 2003
Type Article in Periodical
Magazine / Source Lung Cancer
MU Faculty or unit

Faculty of Medicine

Citation
Field Pneumology
Keywords non small cell lung cancer; gemcitabine; carboplatin; cisplatin; phase III trial
Description The randomized multicenter trial was conducted to compare the tolerability of gemcitabine plus cisplatin GP vs. gemcitabine plus carboplatin GC in chemonaive stage IIIb and IV pts. The enrolled pts, 87 in the GP branch and 89 in GC branch, were balanced demographically and for disease characteristics. Results show that that both regimens were comparable. GC may offer acceptable option for patients unable to receive cisplatin.
Related projects:

You are running an old browser version. We recommend updating your browser to its latest version.